Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Commensal bacteria regulate gene expression and differentiation in vertebrate olfactory systems through transcription factor REST.

Casadei E, Tacchi L, Lickwar CR, Espenschied ST, Davison JM, Muñoz P, Rawls JF, Salinas I.

Chem Senses. 2019 Aug 12. pii: bjz050. doi: 10.1093/chemse/bjz050. [Epub ahead of print]

PMID:
31403159
2.

High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma.

Sepulveda JL, Komissarova EV, Kongkarnka S, Friedman RA, Davison JM, Levy B, Bryk D, Jobanputra V, Del Portillo A, Falk GW, Sonett JR, Lightdale CJ, Abrams JA, Wang TC, Sepulveda AR.

Int J Cancer. 2019 Apr 19. doi: 10.1002/ijc.32351. [Epub ahead of print]

PMID:
31001805
3.

Probiotic and synbiotic therapy in the critically ill: State of the art.

Davison JM, Wischmeyer PE.

Nutrition. 2019 Mar;59:29-36. doi: 10.1016/j.nut.2018.07.017. Epub 2018 Aug 7.

PMID:
30415160
4.

Low-grade dysplasia diagnosis ratio and progression metrics identify variable Barrett's esophagus risk stratification proficiency in independent pathology practices.

Davison JM, Shah MB, Deitrick C, Chennat J, Fasanella KE, McGrath K.

Gastrointest Endosc. 2018 Nov;88(5):807-815.e2. doi: 10.1016/j.gie.2018.06.017. Epub 2018 Jun 23.

PMID:
29944863
5.

Daytime and nighttime casein supplements similarly increase muscle size and strength in response to resistance training earlier in the day: a preliminary investigation.

Joy JM, Vogel RM, Shane Broughton K, Kudla U, Kerr NY, Davison JM, Wildman REC, DiMarco NM.

J Int Soc Sports Nutr. 2018 May 15;15(1):24. doi: 10.1186/s12970-018-0228-9.

6.

Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.

Stachler MD, Camarda ND, Deitrick C, Kim A, Agoston AT, Odze RD, Hornick JL, Nag A, Thorner AR, Ducar M, Noffsinger A, Lash RH, Redston M, Carter SL, Davison JM, Bass AJ.

Gastroenterology. 2018 Jul;155(1):156-167. doi: 10.1053/j.gastro.2018.03.047. Epub 2018 Mar 31.

7.

Zebrafish Transcription Factor ORFeome for Gene Discovery and Regulatory Network Elucidation.

King J, Foster J, Davison JM, Rawls JF, Breton G.

Zebrafish. 2018 Apr;15(2):202-205. doi: 10.1089/zeb.2017.1486. Epub 2017 Nov 27.

8.

Extreme chromosome 17 copy number instability is a prognostic factor in patients with gastroesophageal adenocarcinoma: A retrospective cohort study.

Birkness JE, Spada NG, Miller C, Luketich JD, Nason KS, Sun W, Davison JM.

Genes Chromosomes Cancer. 2018 Jan;57(1):28-34. doi: 10.1002/gcc.22504. Epub 2017 Oct 30.

PMID:
28913947
9.

Microbiota regulate intestinal epithelial gene expression by suppressing the transcription factor Hepatocyte nuclear factor 4 alpha.

Davison JM, Lickwar CR, Song L, Breton G, Crawford GE, Rawls JF.

Genome Res. 2017 Jul;27(7):1195-1206. doi: 10.1101/gr.220111.116. Epub 2017 Apr 6.

10.

ISSHP, an association saving the lives of pregnant women and their babies: (The International Society for the Study of Hypertensions in Pregnancy (ISSHP): Its history).

Davison JM, Lindheimer MD.

Pregnancy Hypertens. 2017 Jan;7:2-28. doi: 10.1016/j.preghy.2016.08.236. Epub 2016 Oct 7. No abstract available.

PMID:
28279443
11.

The Use of Ancillary Stains in the Diagnosis of Barrett Esophagus and Barrett Esophagus-associated Dysplasia: Recommendations From the Rodger C. Haggitt Gastrointestinal Pathology Society.

Srivastava A, Appelman H, Goldsmith JD, Davison JM, Hart J, Krasinskas AM.

Am J Surg Pathol. 2017 May;41(5):e8-e21. doi: 10.1097/PAS.0000000000000819. Review.

PMID:
28248814
12.

5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers.

Van Der Kraak L, Goel G, Ramanan K, Kaltenmeier C, Zhang L, Normolle DP, Freeman GJ, Tang D, Nason KS, Davison JM, Luketich JD, Dhupar R, Lotze MT.

J Immunother Cancer. 2016 Oct 18;4:65. doi: 10.1186/s40425-016-0163-8. eCollection 2016.

13.

A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.

Critchley-Thorne RJ, Davison JM, Prichard JW, Reese LM, Zhang Y, Repa K, Li J, Diehl DL, Jhala NC, Ginsberg GG, DeMarshall M, Foxwell T, Jobe BA, Zaidi AH, Duits LC, Bergman JJ, Rustgi A, Falk GW.

Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):240-248. doi: 10.1158/1055-9965.EPI-16-0640. Epub 2016 Oct 11.

14.

A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus.

Critchley-Thorne RJ, Duits LC, Prichard JW, Davison JM, Jobe BA, Campbell BB, Zhang Y, Repa KA, Reese LM, Li J, Diehl DL, Jhala NC, Ginsberg G, DeMarshall M, Foxwell T, Zaidi AH, Lansing Taylor D, Rustgi AK, Bergman JJ, Falk GW.

Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):958-68. doi: 10.1158/1055-9965.EPI-15-1164. Epub 2016 May 13.

15.

Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging.

Schneider F, Derrick V, Davison JM, Strollo D, Incharoen P, Dacic S.

Mod Pathol. 2016 Jul;29(7):735-42. doi: 10.1038/modpathol.2016.66. Epub 2016 Apr 15.

16.

A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes.

Davison JM, Landau MS, Luketich JD, McGrath KM, Foxwell TJ, Landsittel DP, Gibson MK, Nason KS.

Clin Gastroenterol Hepatol. 2016 Mar;14(3):369-377.e3. doi: 10.1016/j.cgh.2015.10.020. Epub 2015 Oct 26.

17.

TissueCypher(™): A systems biology approach to anatomic pathology.

Prichard JW, Davison JM, Campbell BB, Repa KA, Reese LM, Nguyen XM, Li J, Foxwell T, Taylor DL, Critchley-Thorne RJ.

J Pathol Inform. 2015 Aug 31;6:48. doi: 10.4103/2153-3539.163987. eCollection 2015.

18.

Paired exome analysis of Barrett's esophagus and adenocarcinoma.

Stachler MD, Taylor-Weiner A, Peng S, McKenna A, Agoston AT, Odze RD, Davison JM, Nason KS, Loda M, Leshchiner I, Stewart C, Stojanov P, Seepo S, Lawrence MS, Ferrer-Torres D, Lin J, Chang AC, Gabriel SB, Lander ES, Beer DG, Getz G, Carter SL, Bass AJ.

Nat Genet. 2015 Sep;47(9):1047-55. doi: 10.1038/ng.3343. Epub 2015 Jul 20.

19.

The revised American Joint Committee on Cancer staging system (7th edition) improves prognostic stratification after minimally invasive esophagectomy for esophagogastric adenocarcinoma.

Zahoor H, Luketich JD, Weksler B, Winger DG, Christie NA, Levy RM, Gibson MK, Davison JM, Nason KS.

Am J Surg. 2015 Oct;210(4):610-7. doi: 10.1016/j.amjsurg.2015.05.010. Epub 2015 Jun 26.

20.

Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.

Derks S, Nason KS, Liao X, Stachler MD, Liu KX, Liu JB, Sicinska E, Goldberg MS, Freeman GJ, Rodig SJ, Davison JM, Bass AJ.

Cancer Immunol Res. 2015 Oct;3(10):1123-1129. doi: 10.1158/2326-6066.CIR-15-0046. Epub 2015 Jun 16.

21.

Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.

Singhi AD, Foxwell TJ, Nason K, Cressman KL, McGrath KM, Sun W, Bahary N, Zeh HJ, Levy RM, Luketich JD, Davison JM.

Am J Surg Pathol. 2015 Apr;39(4):487-95. doi: 10.1097/PAS.0000000000000356.

22.

Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases.

Singhi AD, Seethala RR, Nason K, Foxwell TJ, Roche RL, McGrath KM, Levy RM, Luketich JD, Davison JM.

Hum Pathol. 2015 Mar;46(3):366-75. doi: 10.1016/j.humpath.2014.11.021. Epub 2014 Dec 17.

23.

Breast-feeding after transplantation.

Constantinescu S, Pai A, Coscia LA, Davison JM, Moritz MJ, Armenti VT.

Best Pract Res Clin Obstet Gynaecol. 2014 Nov;28(8):1163-73. doi: 10.1016/j.bpobgyn.2014.09.001. Epub 2014 Sep 16. Review.

PMID:
25271063
24.

Immunosuppressive drugs and fetal outcome.

Coscia LA, Constantinescu S, Davison JM, Moritz MJ, Armenti VT.

Best Pract Res Clin Obstet Gynaecol. 2014 Nov;28(8):1174-87. doi: 10.1016/j.bpobgyn.2014.07.020. Epub 2014 Aug 7. Review.

PMID:
25175414
25.

Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.

Zaidi AH, Gopalakrishnan V, Kasi PM, Zeng X, Malhotra U, Balasubramanian J, Visweswaran S, Sun M, Flint MS, Davison JM, Hood BL, Conrads TP, Bergman JJ, Bigbee WL, Jobe BA.

Cancer. 2014 Dec 15;120(24):3902-13. doi: 10.1002/cncr.28963. Epub 2014 Aug 5.

26.

GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival.

Singhi AD, Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Mantha G, Nikiforova M, Bartlett DL, Pai RK.

Hum Pathol. 2014 Aug;45(8):1737-43. doi: 10.1016/j.humpath.2014.04.018. Epub 2014 May 8.

PMID:
24925222
27.

Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma.

Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM.

Mod Pathol. 2014 Dec;27(12):1578-89. doi: 10.1038/modpathol.2014.66. Epub 2014 Apr 25.

28.

The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?

Conrad KP, Davison JM.

Am J Physiol Renal Physiol. 2014 May 15;306(10):F1121-35. doi: 10.1152/ajprenal.00042.2014. Epub 2014 Mar 19. Review.

29.

Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade.

Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Zhu B, Nikiforova M, Bartlett DL, Pai RK.

Mod Pathol. 2014 Nov;27(11):1521-39. doi: 10.1038/modpathol.2014.37. Epub 2014 Mar 14.

30.

Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms.

Davison JM, Hartman DA, Singhi AD, Choudry HA, Ahrendt SA, Zureikat AH, Ramalingam L, Nikiforova M, Pai RK.

Am J Surg Pathol. 2014 May;38(5):583-92. doi: 10.1097/PAS.0000000000000194.

PMID:
24618609
31.

The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma.

Davison JM, Yee M, Krill-Burger JM, Lyons-Weiler MA, Kelly LA, Sciulli CM, Nason KS, Luketich JD, Michalopoulos GK, LaFramboise WA.

PLoS One. 2014 Jan 16;9(1):e79079. doi: 10.1371/journal.pone.0079079. eCollection 2014.

32.

MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.

Davison JM, Ellis ST, Foxwell TJ, Luketich JD, Gibson MK, Kuan SF, Nason KS.

Hum Pathol. 2014 Mar;45(3):540-8. doi: 10.1016/j.humpath.2013.10.020. Epub 2013 Oct 30.

33.

Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium.

Malhotra U, Zaidi AH, Kosovec JE, Kasi PM, Komatsu Y, Rotoloni CL, Davison JM, R C, Irvin, Hoppo T, Nason KS, Kelly LA, Gibson MK, Jobe BA.

PLoS One. 2013 Nov 4;8(11):e78343. doi: 10.1371/journal.pone.0078343. eCollection 2013.

34.

Appropriate use of special stains for identifying Helicobacter pylori: Recommendations from the Rodger C. Haggitt Gastrointestinal Pathology Society.

Batts KP, Ketover S, Kakar S, Krasinskas AM, Mitchell KA, Wilcox R, Westerhoff M, Rank J, Gibson J, Mattia AR, Cummings OW, Davison JM, Naini BV, Dry SM, Yantiss RK; Rodger C Haggitt Gastrointestinal Pathology Society.

Am J Surg Pathol. 2013 Nov;37(11):e12-22. doi: 10.1097/PAS.0000000000000097. Review.

PMID:
24141174
35.

Dysregulated phosphatidylinositol signaling promotes endoplasmic-reticulum-stress-mediated intestinal mucosal injury and inflammation in zebrafish.

Thakur PC, Davison JM, Stuckenholz C, Lu L, Bahary N.

Dis Model Mech. 2014 Jan;7(1):93-106. doi: 10.1242/dmm.012864. Epub 2013 Oct 17.

36.

Pediatric autoimmune enteropathy: an entity frequently associated with immunodeficiency disorders.

Singhi AD, Goyal A, Davison JM, Regueiro MD, Roche RL, Ranganathan S.

Mod Pathol. 2014 Apr;27(4):543-53. doi: 10.1038/modpathol.2013.150. Epub 2013 Sep 20.

37.

HER2 Assessment in Upper Gastrointestinal Tract Adenocarcinoma: A Practical, Algorithmic Approach.

Davison JM, Pai RK.

Surg Pathol Clin. 2013 Sep;6(3):391-403. doi: 10.1016/j.path.2013.05.001. Epub 2013 Jul 19.

PMID:
26839094
38.

Breastfeeding and tacrolimus: is it a reasonable approach?

Armenti VT, Moritz MJ, Davison JM.

Expert Rev Clin Immunol. 2013 Jul;9(7):623-6. doi: 10.1586/1744666X.2013.811042.

PMID:
23899232
39.

Safety considerations: breastfeeding after transplant.

Thiagarajan KM, Arakali SR, Mealey KJ, Cardonick EH, Gaughan WJ, Davison JM, Moritz MJ, Armenti VT.

Prog Transplant. 2013 Jun;23(2):137-46. doi: 10.7182/pit2013803. Review.

PMID:
23782661
40.

Spruelike enteropathy associated with olmesartan: an unusual case of severe diarrhea.

Dreifuss SE, Tomizawa Y, Farber NJ, Davison JM, Sohnen AE.

Case Rep Gastrointest Med. 2013;2013:618071. doi: 10.1155/2013/618071. Epub 2013 Mar 13.

41.

Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.

Ong CA, Shapiro J, Nason KS, Davison JM, Liu X, Ross-Innes C, O'Donovan M, Dinjens WN, Biermann K, Shannon N, Worster S, Schulz LK, Luketich JD, Wijnhoven BP, Hardwick RH, Fitzgerald RC.

J Clin Oncol. 2013 Apr 20;31(12):1576-82. doi: 10.1200/JCO.2012.45.9636. Epub 2013 Mar 18.

42.

Endotherapy for superficial adenocarcinoma of the esophagus: an American experience.

Saligram S, Chennat J, Hu H, Davison JM, Fasanella KE, McGrath K.

Gastrointest Endosc. 2013 Jun;77(6):872-6. doi: 10.1016/j.gie.2013.01.014. Epub 2013 Mar 6.

PMID:
23472998
43.

PET-CT confirms the diagnosis of pyogenic spondylodiscitis complicated by psoas abscess.

Davison JM, Graham JA, Nieves NM, Yoest SM.

BMJ Case Rep. 2013 Jan 23;2013. pii: bcr2012008264. doi: 10.1136/bcr-2012-008264. No abstract available.

44.

Prevention of Barrett esophagus and esophageal adenocarcinoma by smoothened inhibitor in a rat model of gastroesophageal reflux disease.

Gibson MK, Zaidi AH, Davison JM, Sanz AF, Hough B, Komatsu Y, Kosovec JE, Bhatt A, Malhotra U, Foxwell T, Rotoloni CL, Hoppo T, Jobe BA.

Ann Surg. 2013 Jul;258(1):82-8. doi: 10.1097/SLA.0b013e318270500d.

PMID:
23108119
45.

Pregnancy after cardiac transplantation.

Cowan SW, Davison JM, Doria C, Moritz MJ, Armenti VT.

Cardiol Clin. 2012 Aug;30(3):441-52. doi: 10.1016/j.ccl.2012.05.001. Review.

PMID:
22813369
46.

PET-CT aids in the diagnosis of a choroidal mass with retinal detachment in a patient with history of breast cancer and sarcoidosis.

Davison JM, Hotchkiss JH, Fadell AJ, Graham JA.

BMJ Case Rep. 2012 Mar 20;2012. pii: bcr1220115294. doi: 10.1136/bcr.12.2011.5294. No abstract available.

47.

HER2 amplification in gastroesophageal adenocarcinoma: correlation of two antibodies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridization.

Radu OM, Foxwell T, Cieply K, Navina S, Dacic S, Nason KS, Davison JM.

Am J Clin Pathol. 2012 Apr;137(4):583-94. doi: 10.1309/AJCPXQVS6YGHPDCY.

48.

Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated neuroendocrine tumors.

Goodell PP, Krasinskas AM, Davison JM, Hartman DJ.

Am J Clin Pathol. 2012 Apr;137(4):576-82. doi: 10.1309/AJCP92UCXPJMMSDU.

PMID:
22431534
49.

Sec14 like PITPs couple lipid metabolism with phosphoinositide synthesis to regulate Golgi functionality.

Mousley CJ, Davison JM, Bankaitis VA.

Subcell Biochem. 2012;59:271-87. doi: 10.1007/978-94-007-3015-1_9. Review.

50.

Devising powerful genetics, biochemical and structural tools in the functional analysis of phosphatidylinositol transfer proteins (PITPs) across diverse species.

Davison JM, Bankaitis VA, Ghosh R.

Methods Cell Biol. 2012;108:249-302. doi: 10.1016/B978-0-12-386487-1.00013-4.

PMID:
22325607

Supplemental Content

Loading ...
Support Center